(2S)-2-amino-4-[[(2S)-1-[[(6S,9R)-6-(2-amino-2-oxoethyl)-3-[(2S)-2-[(1R,3S)-1,3-dihydroxy-5-oxo-5-[[(3R)-11,19,27,35-tetraamino-3-hydroxyhexatriacontyl]amino]pentyl]pyrrolidine-1-carbonyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
| Internal ID | 97aed6a4-7c2d-4392-8a60-08deeb687db4 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | (2S)-2-amino-4-[[(2S)-1-[[(6S,9R)-6-(2-amino-2-oxoethyl)-3-[(2S)-2-[(1R,3S)-1,3-dihydroxy-5-oxo-5-[[(3R)-11,19,27,35-tetraamino-3-hydroxyhexatriacontyl]amino]pentyl]pyrrolidine-1-carbonyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C70H125N13O13/c1-47(71)27-16-7-3-8-19-30-50(72)31-20-9-4-10-21-32-51(73)33-22-11-5-12-23-34-52(74)35-24-13-6-14-25-36-53(84)38-39-77-62(88)43-54(85)42-60(86)59-37-26-40-83(59)69(94)65-48(2)78-64(90)46-58(67(92)80-57(45-61(76)87)68(93)82-65)81-66(91)56(41-49-28-17-15-18-29-49)79-63(89)44-55(75)70(95)96/h15,17-18,28-29,47-48,50-60,65,84-86H,3-14,16,19-27,30-46,71-75H2,1-2H3,(H2,76,87)(H,77,88)(H,78,90)(H,79,89)(H,80,92)(H,81,91)(H,82,93)(H,95,96)/t47?,48?,50?,51?,52?,53-,54+,55+,56+,57+,58-,59+,60-,65?/m1/s1 |
| InChI Key | UQMLOLISKCIDNY-LJNVPVIVSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C70H125N13O13 |
| Molecular Weight | 1356.80 g/mol |
| Exact Mass | 1355.95198109 g/mol |
| Topological Polar Surface Area (TPSA) | 466.00 Ų |
| XlogP | 1.60 |
| Atomic LogP (AlogP) | 3.37 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 51 |
| There are no found synonyms. |
![2D Structure of (2S)-2-amino-4-[[(2S)-1-[[(6S,9R)-6-(2-amino-2-oxoethyl)-3-[(2S)-2-[(1R,3S)-1,3-dihydroxy-5-oxo-5-[[(3R)-11,19,27,35-tetraamino-3-hydroxyhexatriacontyl]amino]pentyl]pyrrolidine-1-carbonyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid](https://plantaedb.com/storage/docs/compounds/2023/11/7e69ea50-86d3-11ee-b13e-8f32d924f78d.jpg "2D Structure of (2S)-2-amino-4-[[(2S)-1-[[(6S,9R)-6-(2-amino-2-oxoethyl)-3-[(2S)-2-[(1R,3S)-1,3-dihydroxy-5-oxo-5-[[(3R)-11,19,27,35-tetraamino-3-hydroxyhexatriacontyl]amino]pentyl]pyrrolidine-1-carbonyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid")
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5447 | 54.47% |
| Caco-2 | - | 0.8598 | 85.98% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Lysosomes | 0.3950 | 39.50% |
| OATP2B1 inhibitior | - | 0.8600 | 86.00% |
| OATP1B1 inhibitior | + | 0.8390 | 83.90% |
| OATP1B3 inhibitior | + | 0.9249 | 92.49% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9516 | 95.16% |
| P-glycoprotein inhibitior | + | 0.7402 | 74.02% |
| P-glycoprotein substrate | + | 0.8840 | 88.40% |
| CYP3A4 substrate | + | 0.7385 | 73.85% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.7990 | 79.90% |
| CYP3A4 inhibition | - | 0.8916 | 89.16% |
| CYP2C9 inhibition | - | 0.9082 | 90.82% |
| CYP2C19 inhibition | - | 0.8783 | 87.83% |
| CYP2D6 inhibition | - | 0.9376 | 93.76% |
| CYP1A2 inhibition | - | 0.9509 | 95.09% |
| CYP2C8 inhibition | + | 0.7187 | 71.87% |
| CYP inhibitory promiscuity | - | 0.9235 | 92.35% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6487 | 64.87% |
| Eye corrosion | - | 0.9907 | 99.07% |
| Eye irritation | - | 0.8976 | 89.76% |
| Skin irritation | - | 0.7756 | 77.56% |
| Skin corrosion | - | 0.9338 | 93.38% |
| Ames mutagenesis | - | 0.7200 | 72.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3593 | 35.93% |
| Micronuclear | + | 0.8600 | 86.00% |
| Hepatotoxicity | + | 0.5195 | 51.95% |
| skin sensitisation | - | 0.8874 | 88.74% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9500 | 95.00% |
| Nephrotoxicity | - | 0.6579 | 65.79% |
| Acute Oral Toxicity (c) | III | 0.5536 | 55.36% |
| Estrogen receptor binding | + | 0.7510 | 75.10% |
| Androgen receptor binding | + | 0.6990 | 69.90% |
| Thyroid receptor binding | + | 0.5503 | 55.03% |
| Glucocorticoid receptor binding | + | 0.6001 | 60.01% |
| Aromatase binding | + | 0.6463 | 64.63% |
| PPAR gamma | + | 0.7455 | 74.55% |
| Honey bee toxicity | - | 0.7066 | 70.66% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5038 | 50.38% |
| Fish aquatic toxicity | + | 0.7792 | 77.92% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.96% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.43% | 96.09% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 98.98% | 83.82% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.67% | 98.33% |
| CHEMBL236 | P41143 | Delta opioid receptor | 97.40% | 99.35% |
| CHEMBL4801 | P29466 | Caspase-1 | 96.57% | 96.85% |
| CHEMBL233 | P35372 | Mu opioid receptor | 96.13% | 97.93% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.97% | 96.47% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.93% | 91.11% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 95.86% | 97.64% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 94.71% | 98.24% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.69% | 94.45% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 94.44% | 90.17% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.83% | 90.08% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 93.43% | 95.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 93.05% | 96.61% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 92.37% | 94.66% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 92.13% | 97.23% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.02% | 99.17% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 91.89% | 88.42% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.88% | 90.71% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 91.65% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.64% | 97.09% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 91.02% | 96.25% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 90.63% | 98.89% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.59% | 97.14% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 88.62% | 90.20% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.50% | 95.89% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 88.18% | 93.56% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.09% | 93.00% |
| CHEMBL5028 | O14672 | ADAM10 | 88.00% | 97.50% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.82% | 95.56% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 87.52% | 92.29% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 86.59% | 93.03% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 86.40% | 82.69% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 85.41% | 91.19% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.92% | 100.00% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 83.53% | 90.24% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.96% | 95.89% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 81.60% | 97.21% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 81.42% | 89.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163188578 |
| LOTUS | LTS0254119 |
| wikiData | Q105277328 |